U.S. Professional Services Stock News

Earlier in 2026, Navitas Semiconductor announced a pivot away from mobile and low-end consumer applications to concentrate its GaN and SiC power chips on AI data centers, high‑power AI infrastructure, and grid systems, supported by new AI-focused power products. An important angle is that management now frames AI infrastructure as the company’s primary growth platform, effectively repositioning Navitas as a power chip supplier geared to the energy demands of large-scale AI computing rather...

Dividend decision and profitability concerns set the backdrop for PACCAR stock PACCAR (PCAR) is drawing attention as investors weigh a fresh quarterly dividend declaration alongside concerns about weakening profitability, shrinking returns on capital, and more cautious analyst earnings estimates. See our latest analysis for PACCAR. PACCAR's recent 1 month share price return of 9.1% and year to date share price return of 17.5% point to building momentum, while 1 year and 5 year total...

SolarEdge Technologies stock sits in an awkward spot for valuation focused investors, with a sharp 81.2% decline over the past 5 years set against recent share price strength and a valuation score that points to a mixed picture rather than a clear bargain or clear overvaluation. Over 5 years, SolarEdge Technologies has fallen 81.2%, which means anyone who bought and held through that period has seen most of their capital eroded and may now be reassessing what price makes sense. Recent...

Oil above $100 a barrel and US Treasury yields above 4.7% on the 10-year and 5.18% on the 30-year are not just headlines; they directly influence company costs, financing, and valuations. Some stocks can potentially benefit when rates rise or energy prices spike, while others may face pressure from higher fuel bills or more expensive debt. This article walks through three stocks exposed to these twin shocks, explaining one case where the backdrop could be a tailwind and two where it may be a...

Pebblebrook Hotel Trust (PEB) is back in focus after analysts raised earnings estimates again, highlighting a clean streak of positive earnings surprises across the last four quarters and an upgrade to a top analyst rank. See our latest analysis for Pebblebrook Hotel Trust. The recent upgrade in analyst sentiment comes as Pebblebrook Hotel Trust’s share price has moved to US$19.68, with a 90 day share price return of 43.23% and a 1 year total shareholder return of 83.12%, signaling strong...

Social Security reform is back in the headlines, and the bipartisan PROMISE Act has put retirement income security under a brighter spotlight. With projections of a 22% cut to benefits by 2032 if nothing changes, many retirees and near retirees may rethink how much they rely on government programs alone. That is where dividend stocks with consistent payouts and moderate risk scores can play a supporting role. This article looks at 3 dividend stocks from the screener that appear well...

Galaxy Digital has arranged a $3.5b bond financing to build a large data center campus in Texas. CoreWeave (NasdaqGS:CRWV) has agreed to lease the entire IT load under 15 year contracts. The arrangement is focused on providing high density compute capacity for AI and cloud workloads. For CoreWeave, this Texas build out comes as the stock trades at $82.64, with a return of 7.2% over the past week and 4.2% year to date, while it is down 25.7% over the past month and 34.4% over the past year...

Simmons First National Corporation recently reported past second-quarter 2026 results, with net interest income of US$200.63 million, net income of US$66.69 million and net loan charge-offs of US$9.12 million, all measured against the same period a year earlier. The bank also completed a repurchase of 700,000 shares for US$15.06 million, a capital allocation move that sits alongside higher earnings and lower loan charge-offs to shape how investors assess its financial profile. We’ll now...

In recent months, Arista Networks has raised its full-year 2026 revenue outlook on the back of strong AI-driven networking demand and guided to approximately US$2.8 billion in second-quarter revenue, while also launching an AI-powered Edge Threat Management solution that unifies zero trust security and SD-WAN for branch offices. This combination of upgraded outlook, accelerating AI infrastructure adoption, and expansion into branch security reinforces Arista’s push to broaden its role across...

In July 2026, TTM Technologies presented its aerospace, defense, and advanced electronics capabilities at the Farnborough International Airshow in the United Kingdom, highlighting its mission systems, RF components, and complex PCB solutions for global customers. The event underscored TTM's growing role in supplying high-end electronics for AI data center infrastructure and mission-critical defense hardware, reinforcing its position in these specialized markets. We’ll now examine how TTM’s...

New U.S. tariffs on Canadian motor vehicles and related products are set to reshape costs across the auto supply chain, and that ripple effect is already on investors’ radar. While some companies may face higher input prices or trade friction, others could see fresh demand as buyers look for alternative suppliers or lean more on domestic aftermarket options. This article looks at 3 stocks from a U.S. Auto Parts and Aftermarket Suppliers screener that appear positively exposed to this news,...

Tariffs are moving again, and that can quickly change the risk and reward profile for U.S. manufacturers. With new charges on Brazilian and Canadian imports, ongoing levies on metals, autos, timber and semiconductors, and a fresh 100% tariff on many pharmaceuticals, investors are asking which domestic producers might stand to benefit. This article looks at stocks from a U.S. Domestic Manufacturing Stocks screener that are closely exposed to these tariff shifts, and will walk through 3...

Axsome Therapeutics reported that the FDA has accepted its New Drug Application for AXS-12 for the treatment of cataplexy in narcolepsy. The FDA does not plan to hold an advisory committee meeting as part of the review. The filing acceptance marks a key regulatory step for AXS-12, a potential option for a serious sleep disorder with unmet medical need. For Axsome Therapeutics (NasdaqGM:AXSM), this regulatory milestone arrives with the stock trading around $239.62 and a very large 3 year and...

United Rentals stock has delivered a strong 229.4% return over the past five years, yet its valuation checks are sending mixed messages, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples lean the other way. For investors trying to assess what the current US$1,035.06 share price really reflects, the split between these frameworks is central. Over five years United Rentals has returned 229.4%, which puts extra focus on whether recent...

With inflation, energy prices and interest rate expectations all pulling markets in different directions, many investors are looking for leaders whose interests are closely tied to long term outcomes rather than short term headlines. Founder led companies can fit that brief, as founders often have more of their own wealth, reputation and time invested in the business. This article looks at a curated Founder Led Companies screener that focuses on leaders who are personally committed to...

AbbVie stock has delivered a strong 156.7% total return over the past five years. However, there is a clear split in what the valuation tools indicate today. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while traditional market multiples make the shares look expensive, and the overall value score remains low. Over five years, AbbVie has returned 156.7%, which puts extra focus on whether current buyers are paying too much for that track record. Progress...

Merck (NYSE:MRK) is seeing new clinical progress for its KEYTRUDA franchise in Europe and in hard to treat cancers. Agilent received EU approval to use its PD-L1 IHC 22C3 pharmDx test as a companion diagnostic to identify patients eligible for KEYTRUDA in additional gynecologic cancers. Phanes Therapeutics expanded its clinical trial collaboration with Merck to study KEYTRUDA in combination regimens for biliary tract cancer. These updates highlight how Merck is continuing to develop...

HP (HPQ) is back in focus after Goodwall expanded their partnership to bring HP devices and AI skills programs to young people across Brazil and Latin America, tying education access to future customer relationships. See our latest analysis for HP. HP’s recent partnership news sits alongside firm share price momentum, with a 90 day share price return of 24.63% and year to date share price return of 13.47%, while the 5 year total shareholder return of 6.11% and 3 year total shareholder return...

Knight-Swift Transportation Holdings Inc. recently reported past second-quarter 2026 results, with sales of US$1,764.39 million, revenue of US$2,095.71 million, and net income of US$43.19 million, all higher than a year earlier, and earnings per share from continuing operations improving on both a basic and diluted basis. Beyond beating Wall Street expectations, the company highlighted sharper truckload market tightening, better pricing, and improved network efficiency, which together...

Affirm Holdings (AFRM) is back in focus after Bernstein initiated coverage with an Outperform rating, spotlighting the buy now pay later provider’s position across 27 million users and 515,000 merchants worldwide. See our latest analysis for Affirm Holdings. Affirm Holdings’ share price has cooled recently, with a 1-day share price return showing a 1.08% decline and a 7-day share price return showing a 9.54% decline, yet the 90-day share price return of 17.36% and 1-year total shareholder...

Recent data published in Parasites & Vectors showed that Elanco Animal Health’s Credelio QuattroTM kills black-legged and lone star ticks faster and more consistently over 28 days than rival products Simparica Trio and NexGard Plus, while also carrying a U.S. FDA-approved claim for preventing Lyme disease in dogs via rapid tick kill. The studies highlight that Credelio Quattro uniquely maintains an 8-hour speed of kill for black-legged ticks through Day 28, which directly targets the early...

Pinnacle Financial Partners (PNFP) is back in focus after reporting second quarter 2026 earnings, with net income of US$328 million and basic earnings per share from continuing operations of US$2.07. See our latest analysis for Pinnacle Financial Partners. The latest earnings beat has arrived against a mixed backdrop for Pinnacle Financial Partners, with the share price at US$97.36, a modest 1 day share price return of 0.59% and a year to date share price return of 2.38%. The 1 year total...

Houlihan Lokey stock has delivered a 76.5% total return over the past five years, yet its current valuation picture is split, with the Excess Returns intrinsic value estimate pointing to upside while earnings based multiples suggest the shares trade at a richer level. Over five years, a 76.5% return suggests Houlihan Lokey has rewarded patient shareholders, even though the share price has recently been under pressure. For a specialist advisory firm like Houlihan Lokey, expectations for...

Church & Dwight (CHD) is back in focus as investors look ahead to its late July second quarter earnings release, following a series of upside surprises and ongoing margin focused productivity efforts. See our latest analysis for Church & Dwight. At a share price of $97.13, Church & Dwight has a 1-month share price return of 3.62% and a year to date share price return of 17.53%. Its 1-year total shareholder return of 1.38% suggests recent momentum has been stronger in the short term than over...